Extremely Low-Frequency Magnetic Field Enhances the Therapeutic Efficacy of Low-Dose Cisplatin in the Treatment of Ehrlich Carcinoma

Table 1

PCEs, NCEs, MNPCEs induction in bone marrow cells of tumor bearing mice for control and treated groups.

Groups	NCEs/100	PCEs/100	MNPCEs/1000
A	54 ± 0.57*	46 ± 0.57*	11 ± 0.97*
B	57.3 ± 0.33*	42.7 ± 0.33*	11.0 ± 1.15*
C	65.3 ± 0.88*	34.7 ± 0.88	7 ± 1
D	65.3 ± 0.88	34.7 ± 0.88	7.3 ± 0.33

Mice group (A) treated with cisplatin followed by exposure to ELF-MF, mice group (B) treated with cisplatin, mice group (C) treated by exposure to ELF-MF and mice group (D) the control one. Each value represents the mean ± S.E. (𝑛=5, *P < 0.01).